1. Rapid Translation System
    The new RTS 500 Instrument is the first preparative-scale protein expression system that incorporates continuous-exchange cell-free technology (CECF)
  2. AxiChrom™ Chromatography Columns

    The AxiChrom™ column platform is a revolutionary concept in column chromatography that simplifies column handling at all scales from process development to full-scale production.

  3. Gibco BioProduction Services

    Gibco BioProduction Services can support and partner with you no matter what your comfort level is with intellectual property.  Our team of professionals will work with you to provide the best customized solution for your particular situation.  You will receive exceptional customer service from start to finish.

  4. Pharmaceutical Contract Blister Packaging Services

    Ropack provides a number of contract blister packaging services and can produce blister packaging in several different forms, including regular thermo-form, cold-formed, and heat-sealed blister cards.

  5. High Potency API (HPAPI) Development & Manufacturing

    Piramal Pharma Solutions (PPS) is pleased to welcome Ash Stevens LLC as a part of the Piramal Group. Leveraging five decades of Ash Stevens’s operational experience and technical expertise, Piramal’s service offering now includes High Potency API (HPAPI) development and manufacturing capabilities. Located in Riverview, USA, our state-of the-art FDA licensed cGMP facility offers a full range of scale and containment options for high potency API manufacturing.

  6. Active Pharmaceutical Ingredient Development And Manufacture

    Active Pharmaceutical Ingredient (API) production is a critical component of drug development. The efficient synthesis of a molecule is a fundamental requirement of success.

  7. More Shots On Goal Using A Developability Assessment Tool

    Data-driven risk assessment enables smart decisions on development strategy.

  8. Market Research Report: Contract Development And Manufacturing Outsourcing Models

    This market research report reveals the motivations and strategies behind a drug innovators’ decision to outsource, how different outsourcing relationships are selected, and how these factors can impact the decision of which outsourcing model to use (Tactical or Transactional Outsourcing, Preferred Providers, and Strategic Partnerships).